Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial

Hossein Salimnia, Marilynn R. Fairfax, Paul R. Lephart, Paul Schreckenberger, Sharon M. DesJarlais, J. Kristie Johnson, Gwen Robinson, Karen C. Carroll, Amy Greer, Margie Morgan, Raymond Chan, Michael Loeffelholz, Frances Valencia-Shelton, Stephen Jenkins, Audrey N. Schuetz, Judy A. Daly, Trenda Barney, Andrew Hemmert, Kristen J. Kanack

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Sepsis is a major cause of morbidity, mortality, and increased medical expense. Rapid diagnosis improves outcomes and reduces costs. The FilmArray blood culture identification panel (BioFire Diagnostics LLC, Salt Lake City, UT), a highly multiplexed PCR assay, can identify 24 etiologic agents of sepsis (8 Gram-positive, 11 Gram-negative, and 5 yeast species) and three antimicrobial resistance genes (mecA, vanA/B, and blaKPC) from positive blood culture bottles. It provides results in about 1 h with 2 min for assay setup. We present the results of an eight-center trial comparing the sensitivity and specificity of the panel with those of the laboratories' standard phenotypic identification techniques, as well as with molecular methods used to distinguish Acinetobacter baumannii from other members of the A. calcoaceticus-A. baumannii complex and to detect antimicrobial resistance genes. Testing included 2,207 positive aerobic blood culture samples, 1,568 clinical and 639 seeded. Samples were tested fresh or were frozen for later testing within 8 h after the bottles were flagged as positive by an automated blood culture system. At least one organism was detected by the panel in 1,382 (88.1%) of the positive clinical specimens. The others contained primarily off-panel organisms. The panel reported multiple organisms in 81 (5.86%) positive clinical specimens. The unresolved blood culture identification sensitivity for all target detections exceeded 96%, except for Klebsiella oxytoca (92.2%), which achieved 98.3% sensitivity after resolution of an unavoidable phenotypic error. The sensitivity and specificity for vanA/B and blaKPC were 100%; those for mecA were 98.4 and 98.3%, respectively.

Original languageEnglish (US)
Pages (from-to)687-698
Number of pages12
JournalJournal of Clinical Microbiology
Volume54
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Multicenter Studies
Acinetobacter baumannii
Sepsis
Klebsiella oxytoca
Sensitivity and Specificity
Genes
Yeasts
Blood Culture
Morbidity
Costs and Cost Analysis
Polymerase Chain Reaction
Mortality

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Salimnia, H., Fairfax, M. R., Lephart, P. R., Schreckenberger, P., DesJarlais, S. M., Johnson, J. K., ... Kanack, K. J. (2016). Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. Journal of Clinical Microbiology, 54(3), 687-698. https://doi.org/10.1128/JCM.01679-15

Evaluation of the FilmArray Blood Culture Identification Panel : Results of a Multicenter Controlled Trial. / Salimnia, Hossein; Fairfax, Marilynn R.; Lephart, Paul R.; Schreckenberger, Paul; DesJarlais, Sharon M.; Johnson, J. Kristie; Robinson, Gwen; Carroll, Karen C.; Greer, Amy; Morgan, Margie; Chan, Raymond; Loeffelholz, Michael; Valencia-Shelton, Frances; Jenkins, Stephen; Schuetz, Audrey N.; Daly, Judy A.; Barney, Trenda; Hemmert, Andrew; Kanack, Kristen J.

In: Journal of Clinical Microbiology, Vol. 54, No. 3, 01.03.2016, p. 687-698.

Research output: Contribution to journalArticle

Salimnia, H, Fairfax, MR, Lephart, PR, Schreckenberger, P, DesJarlais, SM, Johnson, JK, Robinson, G, Carroll, KC, Greer, A, Morgan, M, Chan, R, Loeffelholz, M, Valencia-Shelton, F, Jenkins, S, Schuetz, AN, Daly, JA, Barney, T, Hemmert, A & Kanack, KJ 2016, 'Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial', Journal of Clinical Microbiology, vol. 54, no. 3, pp. 687-698. https://doi.org/10.1128/JCM.01679-15
Salimnia H, Fairfax MR, Lephart PR, Schreckenberger P, DesJarlais SM, Johnson JK et al. Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. Journal of Clinical Microbiology. 2016 Mar 1;54(3):687-698. https://doi.org/10.1128/JCM.01679-15
Salimnia, Hossein ; Fairfax, Marilynn R. ; Lephart, Paul R. ; Schreckenberger, Paul ; DesJarlais, Sharon M. ; Johnson, J. Kristie ; Robinson, Gwen ; Carroll, Karen C. ; Greer, Amy ; Morgan, Margie ; Chan, Raymond ; Loeffelholz, Michael ; Valencia-Shelton, Frances ; Jenkins, Stephen ; Schuetz, Audrey N. ; Daly, Judy A. ; Barney, Trenda ; Hemmert, Andrew ; Kanack, Kristen J. / Evaluation of the FilmArray Blood Culture Identification Panel : Results of a Multicenter Controlled Trial. In: Journal of Clinical Microbiology. 2016 ; Vol. 54, No. 3. pp. 687-698.
@article{0ce8e869a74e4541b84e10c47ac63c57,
title = "Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial",
abstract = "Sepsis is a major cause of morbidity, mortality, and increased medical expense. Rapid diagnosis improves outcomes and reduces costs. The FilmArray blood culture identification panel (BioFire Diagnostics LLC, Salt Lake City, UT), a highly multiplexed PCR assay, can identify 24 etiologic agents of sepsis (8 Gram-positive, 11 Gram-negative, and 5 yeast species) and three antimicrobial resistance genes (mecA, vanA/B, and blaKPC) from positive blood culture bottles. It provides results in about 1 h with 2 min for assay setup. We present the results of an eight-center trial comparing the sensitivity and specificity of the panel with those of the laboratories' standard phenotypic identification techniques, as well as with molecular methods used to distinguish Acinetobacter baumannii from other members of the A. calcoaceticus-A. baumannii complex and to detect antimicrobial resistance genes. Testing included 2,207 positive aerobic blood culture samples, 1,568 clinical and 639 seeded. Samples were tested fresh or were frozen for later testing within 8 h after the bottles were flagged as positive by an automated blood culture system. At least one organism was detected by the panel in 1,382 (88.1{\%}) of the positive clinical specimens. The others contained primarily off-panel organisms. The panel reported multiple organisms in 81 (5.86{\%}) positive clinical specimens. The unresolved blood culture identification sensitivity for all target detections exceeded 96{\%}, except for Klebsiella oxytoca (92.2{\%}), which achieved 98.3{\%} sensitivity after resolution of an unavoidable phenotypic error. The sensitivity and specificity for vanA/B and blaKPC were 100{\%}; those for mecA were 98.4 and 98.3{\%}, respectively.",
author = "Hossein Salimnia and Fairfax, {Marilynn R.} and Lephart, {Paul R.} and Paul Schreckenberger and DesJarlais, {Sharon M.} and Johnson, {J. Kristie} and Gwen Robinson and Carroll, {Karen C.} and Amy Greer and Margie Morgan and Raymond Chan and Michael Loeffelholz and Frances Valencia-Shelton and Stephen Jenkins and Schuetz, {Audrey N.} and Daly, {Judy A.} and Trenda Barney and Andrew Hemmert and Kanack, {Kristen J.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1128/JCM.01679-15",
language = "English (US)",
volume = "54",
pages = "687--698",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Evaluation of the FilmArray Blood Culture Identification Panel

T2 - Results of a Multicenter Controlled Trial

AU - Salimnia, Hossein

AU - Fairfax, Marilynn R.

AU - Lephart, Paul R.

AU - Schreckenberger, Paul

AU - DesJarlais, Sharon M.

AU - Johnson, J. Kristie

AU - Robinson, Gwen

AU - Carroll, Karen C.

AU - Greer, Amy

AU - Morgan, Margie

AU - Chan, Raymond

AU - Loeffelholz, Michael

AU - Valencia-Shelton, Frances

AU - Jenkins, Stephen

AU - Schuetz, Audrey N.

AU - Daly, Judy A.

AU - Barney, Trenda

AU - Hemmert, Andrew

AU - Kanack, Kristen J.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Sepsis is a major cause of morbidity, mortality, and increased medical expense. Rapid diagnosis improves outcomes and reduces costs. The FilmArray blood culture identification panel (BioFire Diagnostics LLC, Salt Lake City, UT), a highly multiplexed PCR assay, can identify 24 etiologic agents of sepsis (8 Gram-positive, 11 Gram-negative, and 5 yeast species) and three antimicrobial resistance genes (mecA, vanA/B, and blaKPC) from positive blood culture bottles. It provides results in about 1 h with 2 min for assay setup. We present the results of an eight-center trial comparing the sensitivity and specificity of the panel with those of the laboratories' standard phenotypic identification techniques, as well as with molecular methods used to distinguish Acinetobacter baumannii from other members of the A. calcoaceticus-A. baumannii complex and to detect antimicrobial resistance genes. Testing included 2,207 positive aerobic blood culture samples, 1,568 clinical and 639 seeded. Samples were tested fresh or were frozen for later testing within 8 h after the bottles were flagged as positive by an automated blood culture system. At least one organism was detected by the panel in 1,382 (88.1%) of the positive clinical specimens. The others contained primarily off-panel organisms. The panel reported multiple organisms in 81 (5.86%) positive clinical specimens. The unresolved blood culture identification sensitivity for all target detections exceeded 96%, except for Klebsiella oxytoca (92.2%), which achieved 98.3% sensitivity after resolution of an unavoidable phenotypic error. The sensitivity and specificity for vanA/B and blaKPC were 100%; those for mecA were 98.4 and 98.3%, respectively.

AB - Sepsis is a major cause of morbidity, mortality, and increased medical expense. Rapid diagnosis improves outcomes and reduces costs. The FilmArray blood culture identification panel (BioFire Diagnostics LLC, Salt Lake City, UT), a highly multiplexed PCR assay, can identify 24 etiologic agents of sepsis (8 Gram-positive, 11 Gram-negative, and 5 yeast species) and three antimicrobial resistance genes (mecA, vanA/B, and blaKPC) from positive blood culture bottles. It provides results in about 1 h with 2 min for assay setup. We present the results of an eight-center trial comparing the sensitivity and specificity of the panel with those of the laboratories' standard phenotypic identification techniques, as well as with molecular methods used to distinguish Acinetobacter baumannii from other members of the A. calcoaceticus-A. baumannii complex and to detect antimicrobial resistance genes. Testing included 2,207 positive aerobic blood culture samples, 1,568 clinical and 639 seeded. Samples were tested fresh or were frozen for later testing within 8 h after the bottles were flagged as positive by an automated blood culture system. At least one organism was detected by the panel in 1,382 (88.1%) of the positive clinical specimens. The others contained primarily off-panel organisms. The panel reported multiple organisms in 81 (5.86%) positive clinical specimens. The unresolved blood culture identification sensitivity for all target detections exceeded 96%, except for Klebsiella oxytoca (92.2%), which achieved 98.3% sensitivity after resolution of an unavoidable phenotypic error. The sensitivity and specificity for vanA/B and blaKPC were 100%; those for mecA were 98.4 and 98.3%, respectively.

UR - http://www.scopus.com/inward/record.url?scp=84959548995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959548995&partnerID=8YFLogxK

U2 - 10.1128/JCM.01679-15

DO - 10.1128/JCM.01679-15

M3 - Article

C2 - 26739158

AN - SCOPUS:84959548995

VL - 54

SP - 687

EP - 698

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 3

ER -